vs
Side-by-side financial comparison of Incyte (INCY) and SM Energy Co (SM). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $704.9M, roughly 1.8× SM Energy Co). On growth, Incyte posted the faster year-over-year revenue change (20.9% vs -17.3%). Over the past eight quarters, SM Energy Co's revenue compounded faster (12.2% CAGR vs 10.4%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
SM Energy Company is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado.
INCY vs SM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $704.9M |
| Net Profit | $303.3M | — |
| Gross Margin | — | — |
| Operating Margin | 23.7% | 25.9% |
| Net Margin | 23.8% | — |
| Revenue YoY | 20.9% | -17.3% |
| Net Profit YoY | 91.7% | — |
| EPS (diluted) | $1.47 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.5B | $704.9M | ||
| Q3 25 | $1.4B | $811.6M | ||
| Q2 25 | $1.2B | $792.9M | ||
| Q1 25 | $1.1B | $844.5M | ||
| Q4 24 | $1.2B | $852.0M | ||
| Q3 24 | $1.1B | $643.6M | ||
| Q2 24 | $1.0B | $634.6M |
| Q1 26 | $303.3M | — | ||
| Q4 25 | $299.3M | — | ||
| Q3 25 | $424.2M | $155.1M | ||
| Q2 25 | $405.0M | $201.7M | ||
| Q1 25 | $158.2M | $182.3M | ||
| Q4 24 | $201.2M | — | ||
| Q3 24 | $106.5M | $240.5M | ||
| Q2 24 | $-444.6M | $210.3M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 25.9% | ||
| Q3 25 | 32.5% | 30.4% | ||
| Q2 25 | 43.6% | 37.2% | ||
| Q1 25 | 19.5% | 32.7% | ||
| Q4 24 | 25.6% | 33.7% | ||
| Q3 24 | 12.8% | 51.4% | ||
| Q2 24 | -45.8% | 44.0% |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 19.9% | — | ||
| Q3 25 | 31.1% | 19.1% | ||
| Q2 25 | 33.3% | 25.4% | ||
| Q1 25 | 15.0% | 21.6% | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 9.4% | 37.4% | ||
| Q2 24 | -42.6% | 33.1% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $0.94 | ||
| Q3 25 | $2.11 | $1.35 | ||
| Q2 25 | $2.04 | $1.76 | ||
| Q1 25 | $0.80 | $1.59 | ||
| Q4 24 | $0.90 | $1.63 | ||
| Q3 24 | $0.54 | $2.09 | ||
| Q2 24 | $-2.04 | $1.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $368.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $4.8B |
| Total Assets | $7.3B | $9.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $368.0M | ||
| Q3 25 | $2.5B | $162.3M | ||
| Q2 25 | $2.0B | $101.9M | ||
| Q1 25 | $1.9B | $54.0K | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.3B | $1.7B | ||
| Q2 24 | $987.3M | $487.9M |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.2B | $4.8B | ||
| Q3 25 | $4.7B | $4.7B | ||
| Q2 25 | $4.2B | $4.6B | ||
| Q1 25 | $3.7B | $4.4B | ||
| Q4 24 | $3.4B | $4.2B | ||
| Q3 24 | $3.2B | $4.1B | ||
| Q2 24 | $3.0B | $3.8B |
| Q1 26 | $7.3B | — | ||
| Q4 25 | $7.0B | $9.3B | ||
| Q3 25 | $6.3B | $9.1B | ||
| Q2 25 | $5.8B | $9.0B | ||
| Q1 25 | $5.7B | $8.8B | ||
| Q4 24 | $5.4B | $8.6B | ||
| Q3 24 | $5.0B | $8.0B | ||
| Q2 24 | $4.7B | $6.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $451.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $451.9M | ||
| Q3 25 | $559.4M | $505.0M | ||
| Q2 25 | $44.7M | $571.1M | ||
| Q1 25 | $266.1M | $483.0M | ||
| Q4 24 | $381.2M | $578.4M | ||
| Q3 24 | $310.9M | $452.3M | ||
| Q2 24 | $-575.6M | $476.4M |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | — | ||
| Q3 25 | 1.32× | 3.26× | ||
| Q2 25 | 0.11× | 2.83× | ||
| Q1 25 | 1.68× | 2.65× | ||
| Q4 24 | 1.89× | — | ||
| Q3 24 | 2.92× | 1.88× | ||
| Q2 24 | — | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.